death
per
death
per
death
per
death
per
death
per
med
describ
subgroup
norwalk
viru
prototyp
genogroup
genotyp
viru
noroviru
genom
approxim
kilobas
size
consist
three
open
read
frame
first
encod
nonstructur
protein
essenti
viru
replic
second
open
read
frame
encod
major
capsid
protein
viral
protein
express
recombin
protein
molecul
autoassembl
viruslik
particl
critic
studi
norovir
epidemiolog
immun
human
norovirus
yet
adapt
cell
cultur
diagnosi
gener
depend
amplif
viru
gene
polymeras
chain
reaction
pcr
see
later
rotavirus
belong
famili
reovirida
larg
icosahedr
nonenvelop
virus
segment
doublestrand
rna
genom
triplelay
protein
coat
rotavirus
classifi
group
g
basi
presenc
crossreact
antigen
epitop
overal
genet
related
group
rotavirus
princip
enter
pathogen
human
mani
speci
group
b
virus
identifi
sporad
outbreak
adult
diarrheal
ill
china
recent
studi
children
sporad
gastroenter
princip
india
group
c
rotavirus
rel
infrequ
associ
diarrheal
diseas
human
anim
around
world
group
g
rotavirus
isol
anim
primarili
avian
speci
rotavirus
particl
three
concentr
layer
protein
core
compos
segment
doublestrand
rna
genom
intermedi
layer
form
abund
antigen
structur
viral
protein
extern
layer
compos
genom
compos
segment
doublestrand
rna
togeth
approxim
kilobas
encod
six
structur
six
nonstructur
protein
case
among
virtual
rna
virus
rotaviru
rna
polymeras
error
prone
along
select
pressur
evolut
immun
drive
viral
divers
rotavirus
gene
reassort
mix
gene
segment
differ
parent
virus
cell
coinfect
two
strain
rearrang
viral
genom
also
contribut
genet
divers
reassort
gene
segment
anim
human
rotaviru
strain
also
occur
natur
set
especi
less
develop
countri
viral
agent
caus
human
acut
infecti
gastroenter
difficult
distinguish
diseas
caus
rotavirus
norovirus
includ
sapoviru
like
noroviru
member
calicivirida
famili
enter
adenovirus
chapter
belong
type
astrovirus
tabl
frequenc
detect
pcr
assay
virus
individu
acut
gastroenter
depend
set
almost
alway
detect
less
frequent
rotavirus
norovirus
coronavirus
chapter
torovirus
picobirnavirus
picornaviru
chapter
bocaviru
parechovirus
pestivirus
also
isol
occasion
person
acut
gastroenter
role
caus
agent
enter
diseas
remain
uncertain
among
patient
acut
gastroenter
etiolog
agent
found
approxim
case
time
norovirus
appear
undergo
antigen
drift
respons
acquisit
immun
gener
popul
much
like
influenza
virus
present
gastroenter
case
around
world
frequent
caus
noroviru
strain
new
strain
gener
evolv
everi
year
owe
antigen
drift
outbreak
frequent
take
place
set
close
human
contact
militari
establish
cruis
ship
nurs
home
school
especi
cold
dri
weather
see
tabl
viral
spread
enhanc
high
level
infect
norovirus
data
suggest
particl
constitut
infecti
dose
norovirus
also
respons
sporad
gastroenter
children
younger
year
develop
develop
countri
overal
estim
norovirus
annual
caus
outpati
visit
hospit
among
children
develop
countri
well
death
children
younger
year
develop
countri
incid
rotavir
diseas
similar
children
develop
develop
countri
suggest
measur
access
clean
water
replac
need
effect
vaccin
introduct
effect
vaccin
rotaviru
estim
respons
annual
death
worldwid
develop
countri
rotaviru
rare
fatal
introduct
vaccin
unit
state
result
hospit
rotavirusmedi
gastroenter
children
year
age
temper
zone
world
rotavir
infect
occur
primarili
epidem
peak
cooler
month
year
see
tabl
pattern
seen
howev
countri
within
degre
equat
infect
occur
endem
fashion
yearround
introduct
rotaviru
vaccin
yearli
wave
rotavir
ill
spread
across
unit
state
europ
follow
peculiar
spatiotempor
pattern
unit
state
pattern
spread
correl
variat
birth
rate
therebi
suggest
number
babi
experienc
first
infect
one
primari
driver
rotaviru
epidem
high
birth
rate
develop
countri
may
also
influenc
differenti
epidemiolog
distribut
rotavirus
antibodi
outer
capsid
protein
basi
serotyp
classif
rotavirus
g
glycoprotein
p
proteasesensit
serotyp
technic
reason
p
serotyp
reagent
infrequ
avail
classif
base
p
genotyp
provid
bracket
worldwid
human
infect
caus
five
type
group
rotaviru
p
far
common
approxim
strain
follow
p
p
p
p
develop
area
like
india
brazil
africa
p
rotavirus
respect
frequent
encount
human
rotaviru
strain
may
arisen
reassort
bovin
porcin
rotavirus
high
preval
virus
recent
observ
sever
countri
therebi
suggest
serotyp
may
emerg
rotaviru
strain
histoblood
group
antigen
hbga
receptor
norovirus
determin
suscept
diseas
strainspecif
manner
hbga
complex
carbohydr
oligosaccharid
link
protein
lipid
express
mucos
epithelia
digest
tract
three
major
famili
hbga
abo
lewi
secretor
famili
involv
bind
norovirus
secretor
statu
person
control
fucosyltransferas
gene
secretorneg
individu
specif
resist
infect
norwalk
viru
gii
virus
although
noroviru
rna
detect
blood
stream
patient
noroviru
gastroenter
site
primari
viral
replic
probabl
gastrointestin
tract
consist
strong
associ
vomit
noroviru
diseas
gastric
empti
delay
proxim
jejun
biopsi
specimen
show
blunt
villi
crypt
cell
hyperplasia
cytoplasm
vacuol
sometim
increas
epitheli
cell
apoptosi
function
alter
epitheli
barrier
like
occur
unknown
present
effect
persist
immun
context
natur
infect
infecti
dose
gener
quit
low
rotavirus
replic
villu
tip
cell
small
bowel
patholog
process
includ
shorten
atrophi
villi
mononuclear
infiltr
lamina
propria
distent
cisterna
endoplasm
reticulum
howev
sever
clinic
diseas
directli
relat
extent
intestin
diseas
rather
relat
level
viral
rna
stool
initi
phase
diseas
alter
intestin
secret
motil
permeabl
contribut
pathophysiolog
mechan
diarrhea
later
cours
diseas
malabsorpt
occur
rotavir
viral
enterotoxin
mediat
least
part
earli
secretori
compon
diarrhea
also
postul
viral
infect
increas
intestin
motil
stimul
enter
nervou
system
possibl
whether
degre
enterotox
effect
clinic
relev
children
anim
speci
remain
determin
infect
individu
short
period
viremia
clinic
consequ
unclear
correl
level
fever
rotaviru
serum
iga
level
measur
shortli
natur
infect
children
gener
correl
intestin
iga
level
appear
correl
protect
one
explan
recurr
rotaviru
noroviru
infect
protect
reinfect
mediat
intestin
iga
longlast
human
anoth
explan
protect
depend
neutral
antibodi
one
highli
variabl
outer
rotavir
protein
howev
monoval
p
vaccin
induc
signific
protect
strain
differ
serotyp
therebi
support
conclus
protect
immun
rotaviru
infect
part
heterotyp
clinic
manifest
noroviru
infect
variabl
depend
part
age
individu
infect
one
third
infect
asymptomat
symptom
includ
diarrhea
nausea
vomit
abdomin
cramp
fever
malais
gener
persist
day
children
younger
year
diseas
typic
begin
sudden
onset
vomit
last
day
viru
shed
low
titer
week
otherwis
healthi
individu
year
patient
sever
immunodefici
syndrom
neonat
prematur
infant
vomit
often
symptom
infect
associ
necrot
enterocol
support
diagnosi
noroviru
outbreak
follow
four
criteria
propos
vomit
half
affect
person
mean
median
incub
period
hour
mean
median
durat
ill
hour
absenc
bacteri
pathogen
stool
cultur
rotaviru
diarrhea
dehydr
tend
sever
ill
caus
childhood
enter
pathogen
rotaviru
diarrhea
wateri
persist
approxim
day
often
preced
sudden
onset
vomit
frequent
accompani
fever
dehydr
incub
period
rotaviru
estim
less
hour
viral
excret
fece
persist
day
major
children
rare
persist
day
excret
time
longer
examin
sensit
pcrbase
assay
rather
solidphas
immunoassay
age
year
virtual
children
acquir
immun
rotaviru
sever
diseas
age
uncommon
revers
transcriptionpcr
rtpcr
current
procedur
choic
detect
noroviru
clinic
specimen
food
water
although
enzymelink
immunosorb
assay
elisa
detect
norovirus
avail
europ
sensit
genotyp
depend
diagnost
specif
sensit
vari
basi
divers
circul
strain
popul
moreov
immunoassay
easili
adapt
detect
new
strain
noroviru
rna
detect
rtpcr
stool
sampl
healthi
individu
find
complic
diagnosi
noroviru
gastroenter
although
relationship
diseas
symptom
viral
load
fulli
establish
quantit
realtim
rtpcr
propos
establish
rel
threshold
posit
attribut
diseas
noroviru
introduct
rotaviru
vaccin
develop
countri
well
moder
sever
diarrheal
episod
young
children
rotaviru
season
due
rotaviru
tropic
countri
presenc
enter
pathogen
absenc
season
occurr
rotavir
diseas
make
difficult
determin
diarrheal
episod
caus
rotaviru
without
diagnost
assay
numer
elisa
rotaviru
commerci
avail
gener
sensit
specif
easi
use
condit
pcr
increas
sensit
detect
rotaviru
permit
easi
type
virus
pcrbase
method
howev
healthi
children
younger
year
may
rotaviru
posit
difficult
associ
detect
viru
gastroenter
thu
elisa
quantit
rtpcr
use
threshold
level
noroviru
prefer
diagnosi
rotaviru
gastroenter
develop
noroviru
vaccin
human
challeng
owe
great
degre
antigen
heterogen
among
circul
strain
propens
norovirus
undergo
antigen
drift
lack
known
correl
protect
high
percentag
alcoholbas
sanit
ethanol
povidoneiodin
antisept
superior
alcoholbas
sanit
reduc
noroviru
contamin
simpl
household
antimicrobi
hand
soap
handwash
tap
water
also
decreas
viral
contamin
rotaviru
vaccin
base
two
differ
approach
one
type
vaccin
use
mixtur
reassort
virus
part
human
rotaviru
part
anim
rotaviru
provid
attenu
anoth
approach
use
singl
attenu
human
viru
neither
type
vaccin
prevent
subsequ
rotaviru
infect
mild
ill
type
prevent
sever
ill
first
vaccin
rotashield
wyethlederl
use
mix
rhesushuman
rotaviru
effect
licens
use
unit
state
subsequ
withdrawn
market
associ
intussuscept
subsequ
two
secondgener
vaccin
shown
larg
studi
safe
without
detect
risk
intussuscept
effect
costeffect
develop
develop
countri
rotateq
merck
modifi
pentaval
vaccin
made
bovin
human
viru
rotarix
glaxosmithklin
monoval
attenu
human
viru
vaccin
protect
rate
develop
middleincom
countri
vaccin
similar
vari
rotaviru
diseas
sever
gastroenter
two
vaccin
may
efficaci
sever
diseas
poorest
develop
countri
howev
even
reduc
effect
two
licens
vaccin
still
costeffect
world
health
organ
recommend
routin
use
vaccin
noroviru
rotaviru
diseas
resolv
within
day
without
treatment
basic
therapeut
goal
prevent
acut
dehydr
recommend
oral
rehydr
salt
solut
osmolar
mmoll
effect
higher
osmolar
solut
rehydr
rapid
ageappropri
refeed
recommend
rotaviru
diseas
induc
selflimit
intestin
lactas
defici
lactosecontain
product
particularli
matern
milk
withheld
passiv
oral
immunotherapi
divers
prepar
immunoglobulin
shorten
durat
rotaviru
infect
probabl
econom
feasibl
immunodefici
patient
lowbirthweight
infant
lactobacillu
bacterium
present
yogurt
safe
limit
studi
appear
treatment
moder
effect
treatment
acut
rotaviru
gastroenter
nonetheless
differ
prepar
lactobacilli
vari
greatli
dose
bacteria
gener
recommend
use
issu
sever
studi
develop
countri
shown
zinc
supplement
mgday
infant
younger
month
mgday
older
children
use
treatment
prevent
diarrhea
studi
need
determin
whether
treatment
use
develop
develop
countri
present
pharmacolog
treatment
rotaviru
noroviru
diarrhea
recommend
racecadotril
mgkg
per
day
enkephalinas
inhibitor
act
enter
nervou
system
shown
use
adjunct
treat
rotavir
diarrhea
sever
small
studi
ondansetron
mgkg
per
day
serotonin
antagonist
effect
reduc
emesi
gastroenter
phase
oral
rehydr
sever
small
studi
nitazoxanid
mgkg
per
day
help
treatment
rotaviru
gastroenter
studi
need
variou
prepar
gener
recommend
treatment
rotaviru
diarrhea
